Clinical study to Evaluate Safety And Efficacy of Bozidan(Pyrethrum Indicum)in the management of Niqris Muzmin (Chronic Gout).

Central council for Research in Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Irrespective of all genders
•Patients between 18-65 years of age
•Patients Fulfilling the criteria of American College of Rheumatology(ACR) for diagnosing gouty arthritis including clinical features, laboratory and radiological finding , having serum uric acid level >7mg/dl in males and Ë?6mg/dl in females17.
•Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily

•Patients below 18 and above 65 years of age
•Pregnant and lactating mothers
•Patients who fail to give consent
•Patients of gout associated with any systemic disorder which interfere with patient study
•Patients of gout associated with any severe arthritic condition such as rheumatoid arthritis, septic arthritis.
•Patients suffering from anemia and other blood dyscrasias like leukemia, haemophilia,etc
•Patients suffering from congenital gout
•Any other disease other than Gout(Gouty arthritis).

发起方

Central council for Research in Unani Medicine New Delhi